PRedicting Outcomes For Crohn's dIsease using a moLecular biomarkEr (PROFILE): protocol for a multicentre, randomised, biomarker-stratified trial.

MLA

Parkes, Miles, et al. “PRedicting Outcomes For Crohn’s DIsease Using a MoLecular BiomarkEr (PROFILE): Protocol for a Multicentre, Randomised, Biomarker-Stratified Trial.” BMJ Open, vol. 8, no. 12, Dec. 2018, p. e026767. EBSCOhost, https://doi.org/10.1136/bmjopen-2018-026767.

APA

Parkes, M., Noor, N. M., Dowling, F., Leung, H., Bond, S., Whitehead, L., Upponi, S., Kinnon, P., Sandham, A. P., Lyons, P. A., McKinney, E. F., Smith, K. G. C., & Lee, J. C. (2018). PRedicting Outcomes For Crohn’s dIsease using a moLecular biomarkEr (PROFILE): protocol for a multicentre, randomised, biomarker-stratified trial. BMJ Open, 8(12), e026767. https://doi.org/10.1136/bmjopen-2018-026767

Chicago

Parkes, Miles, Nurulamin M Noor, Francis Dowling, Harvey Leung, Simon Bond, Lynne Whitehead, Sara Upponi, et al. 2018. “PRedicting Outcomes For Crohn’s DIsease Using a MoLecular BiomarkEr (PROFILE): Protocol for a Multicentre, Randomised, Biomarker-Stratified Trial.” BMJ Open 8 (12): e026767. doi:10.1136/bmjopen-2018-026767.